Washington Gov. Gary Locke unveiled a plan to help senior citizens purchase prescription drugs at lower costs.
Locke announced that the program, called AWARDS, is intended to offer lower prescription drug costs for Washington residents aged 55 and older, but it may be expanded by the legislature to include more Washington residents.
"Drug prices are going through the roof, and older Washington residents are suffering the most," Locke said. "My new program will let seniors, many of whom are on fixed incomes, buy prescription drugs at a lower cost."
Locke said the plan will allow Washington residents aged 55 and older to pay $15 per individual and $25 per family each year to join a "prescription drug buyer's club." Their purchases, at participating pharmacies, will be merged with the buying power of the state Uniform Medical Plan to buy drugs at substantially lower costs. Locke said AWARDS members can expect to pay from 12% to 30% less than retail prices for prescription drugs. If members order from a mail service, they can expect discounts from 20% to 49%. Discounts will vary, depending on an individual's drug profile and current use of generic drugs.
According to Locke, the state government will combine its purchasing power across agencies and join forces with a pharmacy benefit manager to get additional savings on the $376 million state government spends now on prescription drugs.
"If ever there was a compelling need to help our citizens, it is now," Locke said. "Tens of thousands of older Washington citizens need one or more prescription drugs to stay healthy, and sometimes to stay alive. Yet the cost of these drugs is skyrocketing, and fewer seniors can afford them. We need to help our older citizens now."
A spokesperson for the Washington-based Pharmaceutical Research and Manufacturers of America described the proposal as a "concept paper" with a "lot of details that still needed to be filled in," and said they would not comment on it until they saw legislative and regulatory details. PR
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.